JP2025518638A5 - - Google Patents
Info
- Publication number
- JP2025518638A5 JP2025518638A5 JP2025513495A JP2025513495A JP2025518638A5 JP 2025518638 A5 JP2025518638 A5 JP 2025518638A5 JP 2025513495 A JP2025513495 A JP 2025513495A JP 2025513495 A JP2025513495 A JP 2025513495A JP 2025518638 A5 JP2025518638 A5 JP 2025518638A5
- Authority
- JP
- Japan
- Prior art keywords
- transposase
- protein
- vitro method
- nucleic acid
- aptamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263341619P | 2022-05-13 | 2022-05-13 | |
| US63/341,619 | 2022-05-13 | ||
| EP22191966 | 2022-08-24 | ||
| EP22191966.5 | 2022-08-24 | ||
| PCT/EP2023/062736 WO2023218021A1 (en) | 2022-05-13 | 2023-05-12 | Use of transposases for improving transgene expression and nuclear localization |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025518638A JP2025518638A (ja) | 2025-06-18 |
| JP2025518638A5 true JP2025518638A5 (cg-RX-API-DMAC7.html) | 2026-04-08 |
Family
ID=86605260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025513495A Pending JP2025518638A (ja) | 2022-05-13 | 2023-05-12 | 導入遺伝子の発現および核局在化を改善するためのトランスポザーゼの使用 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4522735A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025518638A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250010025A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119487184A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023269540A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3253152A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023218021A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110047635A1 (en) * | 2006-08-28 | 2011-02-24 | University of Hawail | Methods and compositions for transposon-mediated transgenesis |
| CA3082450A1 (en) * | 2017-11-21 | 2019-05-31 | Crispr Therapeutics Ag | Materials and methods for treatment of autosomal dominant retinitis pigmentosa |
| US12338453B2 (en) * | 2018-12-17 | 2025-06-24 | Consejo Superior De Investigaciones Científicas (Csic) | Method for the introduction of genetic information in cell by site-specific integration system |
| WO2020243085A1 (en) | 2019-05-24 | 2020-12-03 | The Trustees Of Columbia University In The City Of New York | Engineered cas-transposon system for programmable and site-directed dna transpositions |
| CN115968301A (zh) * | 2020-04-20 | 2023-04-14 | 综合Dna技术公司 | 优化的蛋白融合和接头 |
| MX2022015284A (es) * | 2020-06-05 | 2023-01-19 | Univ California | Composiciones y metodos para la edicion del epigenoma. |
| CA3173696A1 (en) * | 2020-07-17 | 2022-01-20 | Volker Sandig | Hyperactive transposons and transposases |
| AU2021403660A1 (en) | 2020-12-16 | 2023-07-06 | Universitat Pompeu Fabra | Programmable transposases and uses thereof |
-
2023
- 2023-05-12 KR KR1020247040630A patent/KR20250010025A/ko active Pending
- 2023-05-12 CN CN202380039707.0A patent/CN119487184A/zh active Pending
- 2023-05-12 AU AU2023269540A patent/AU2023269540A1/en active Pending
- 2023-05-12 EP EP23726939.4A patent/EP4522735A1/en active Pending
- 2023-05-12 JP JP2025513495A patent/JP2025518638A/ja active Pending
- 2023-05-12 CA CA3253152A patent/CA3253152A1/en active Pending
- 2023-05-12 WO PCT/EP2023/062736 patent/WO2023218021A1/en not_active Ceased